Atea Pharmaceuticals, Inc. Common Stock (AVIR) News
Latest headlines that mention AVIR, newest first · each headline opens the original publisher
- Last price
- $3.93
- Day change
- -1.50%
- Next earnings
- —
AVIR headlines
last 30 daysPhase 3 hepatitis C data met its endpoints and funding now extends into mid-2028.
AVIR news alerts
Get an alert by email or push when a new headline mentions AVIR.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.